当前位置: 首页 > 详情页

Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China [2]Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, 100053, China [3]Capital Medical University, Beijing, 100069, China
出处:
ISSN:

关键词: HucMSCs Exosomes PDAC MiRNAs Signaling pathways

摘要:
Although human umbilical cord mesenchymal stem cells (hucMSCs) can contribute to the growth of tumors, including pancreatic ductal adenocarcinoma (PDAC), however, little is known about the exact mechanisms by which the exosomes secreted from hucMSCs (hucMSCs-exo) have an oncogenic effect on the physiopathology of PDAC. The effects of hucMSCs on tumor development are attributed to hucMSCs-exo, which deliver unique proteins and miRNAs to cancer cells.HucMSCs and exosomes were isolated and confirmed via transmission electron microscopy, nanoparticle tracking analysis and western blot. The nude mice were inoculated subcutaneously on both flanks with human pancreatic cancer Panc-1 cells (1 × 106), and hucMSCs-exo were directly administered via intratumoral injection once a day for three days each week. Cell proliferation assays were performed using a Cell Counting Kit-8 assay and the cell invasion assay was performed using Transwell assay. The miRNA data were predicted and analyzed by miRanda software. The analysis of the target genes of the miRNAs was proformed with the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases.Firstly, we observed that hucMSCs-exo promoted Panc-1 and BxPC3 cell growth by increasing proliferation and migration in vitro. Secondly, in a xenograft tumor model, hucMSCs-exo increased the growth of Panc-1 cells. Thirdly, high-throughput sequencing of hucMSCs-exo showed that hsa-miR-148a-3p, hsa-miR-100-5p, hsa-miR-143-3p, hsa-miR-21-5p and hsa-miR-92a-3p were highly expressed. For the five identified miRNAs, 1308 target genes were predicted by miRanda software. From the GO and KEGG analyses of the target genes of the identified miRNAs, it was found that the main GO function was the regulation of cellular glucuronidation, and the main KEGG metabolic pathway involved the metabolism of ascorbic acid and aldehyde acid. These processes are related to the occurrence and development of pancreatic cancer. Finally, we observed that miR-100-5p promoted Panc-1 and BxPC3 cell growth in vitro and in vivo.Here, by utilizing exosomes secreted from hucMSCs, we systematically investigated the effects of hucMSCs-exo on PDAC growth in vitro and in vivo for the first time. Building on these results, we provided new insights into the role of hucMSCs-exo in the PDAC growth and revealed the attractive communication between hucMSCs and PDAC cells that occurs through MSCs-exosomes-miRNAs.Copyright © 2021. Published by Elsevier Ltd.

基金:

基金编号: 2020-1-2012 Z171100001017077andZ191100006619038 2014-3-058 7182063

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 4 区 生物
小类 | 3 区 解剖学与形态学 4 区 细胞生物学
最新[2023]版:
大类 | 4 区 生物学
小类 | 3 区 解剖学与形态学 4 区 细胞生物学
JCR分区:
出版当年[2019]版:
Q2 ANATOMY & MORPHOLOGY Q4 CELL BIOLOGY
最新[2023]版:
Q1 ANATOMY & MORPHOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China [2]Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, 100053, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China [2]Clinical Center for Acute Pancreatitis, Capital Medical University, Beijing, 100053, China [*1]Department of General Surgery, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院